Literature DB >> 18849075

Characterization of natural human antagonistic soluble CD40 isoforms produced through alternative splicing.

Dani Eshel1, Amir Toporik, Tali Efrati, Sigal Nakav, Aviva Chen, Amos Douvdevani.   

Abstract

CD40, a TNF receptor (TNFR) family member, is composed of four cysteine rich domains (CRDs) followed by a transmembrane domain and a signaling intracellular C-terminus. CD154 ligation to CD40 regulates major inflammatory and immune processes. A natural soluble form of CD40 was detected in uremic patient's serum which might be alternative splicing product. Our aim was to identify CD40 isoforms produced by primary human cells and to evaluate their biological activity. By RT-PCR, we isolated from primary human cells three major products differing from the expected wild type (WT) transcript which lacks exon 5 (CD40-5), exon 6 (CD40-6) and both exons 5 and 6 (CD40-5 + 6). The first two were predicted computationally to be soluble decoy receptors with various CRDs numbers. Recombinant soluble CD40 (sCD40) isoforms containing either three or four CRDs are able to bind coated surfaces or membranous CD154 while the sCD40 isoform containing 2 CRDs did not. sCD40 proteins inhibited RANTES secretion, but did not block B cell proliferation induced by soluble CD154. These data suggest that sCD40 natural isoforms encompassing either three or four CRDs might exert different antagonistic effects from known CD154 antibodies by recognition of only membranous CD154.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849075     DOI: 10.1016/j.molimm.2008.08.280

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  11 in total

1.  A genome-wide association study identifies three new risk loci for Kawasaki disease.

Authors:  Yoshihiro Onouchi; Kouichi Ozaki; Jane C Burns; Chisato Shimizu; Masaru Terai; Hiromichi Hamada; Takafumi Honda; Hiroyuki Suzuki; Tomohiro Suenaga; Takashi Takeuchi; Norishige Yoshikawa; Yoichi Suzuki; Kumi Yasukawa; Ryota Ebata; Kouji Higashi; Tsutomu Saji; Yasushi Kemmotsu; Shinichi Takatsuki; Kazunobu Ouchi; Fumio Kishi; Tetsushi Yoshikawa; Toshiro Nagai; Kunihiro Hamamoto; Yoshitake Sato; Akihito Honda; Hironobu Kobayashi; Junichi Sato; Shoichi Shibuta; Masakazu Miyawaki; Ko Oishi; Hironobu Yamaga; Noriyuki Aoyagi; Seiji Iwahashi; Ritsuko Miyashita; Yuji Murata; Kumiko Sasago; Atsushi Takahashi; Naoyuki Kamatani; Michiaki Kubo; Tatsuhiko Tsunoda; Akira Hata; Yusuke Nakamura; Toshihiro Tanaka
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

Review 2.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

3.  Assessment of CD40 and CD40L expression in rheumatoid arthritis patients, association with clinical features and DAS28.

Authors:  Ilce Valeria Román-Fernández; Mariel García-Chagollán; Sergio Cerpa-Cruz; Luis Felipe Jave-Suárez; Claudia Azucena Palafox-Sánchez; Samuel García-Arellano; Gabriela Athziri Sánchez-Zuno; José Francisco Muñoz-Valle
Journal:  Clin Exp Med       Date:  2019-07-16       Impact factor: 3.984

Review 4.  The signaling role of CD40 ligand in platelet biology and in platelet component transfusion.

Authors:  Chaker Aloui; Antoine Prigent; Caroline Sut; Sofiane Tariket; Hind Hamzeh-Cognasse; Bruno Pozzetto; Yolande Richard; Fabrice Cognasse; Sandrine Laradi; Olivier Garraud
Journal:  Int J Mol Sci       Date:  2014-12-03       Impact factor: 5.923

5.  Multiple sclerosis risk variants alter expression of co-stimulatory genes in B cells.

Authors:  Ide Smets; Barnaby Fiddes; Josselyn E Garcia-Perez; Di He; Klara Mallants; Wenjia Liao; James Dooley; George Wang; Stephanie Humblet-Baron; Bénédicte Dubois; Alastair Compston; Joanne Jones; Alasdair Coles; Adrian Liston; Maria Ban; An Goris; Stephen Sawcer
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

6.  Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease.

Authors:  Jeffrey X Xie; Helen Alderson; James Ritchie; Philip A Kalra; Yanmei Xie; Kaili Ren; Hanh Nguyen; Tian Chen; Pamela Brewster; Rajesh Gupta; Lance D Dworkin; Deepak Malhotra; Christopher J Cooper; Jiang Tian; Steven T Haller
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 7.  Exploring the RNA Gap for Improving Diagnostic Yield in Primary Immunodeficiencies.

Authors:  Jed J Lye; Anthony Williams; Diana Baralle
Journal:  Front Genet       Date:  2019-12-11       Impact factor: 4.599

8.  Association of soluble CD40 levels with -1 C > T CD40 polymorphism and chronic kidney disease in systemic lupus erythematosus.

Authors:  Raziel Tapia-Llanos; José F Muñoz-Valle; Ilce V Román-Fernández; Miguel Marín-Rosales; Diana C Salazar-Camarena; Alvaro Cruz; Gerardo Orozco-Barocio; Jorge A Guareña-Casillas; Edith Oregon-Romero; Claudia A Palafox-Sánchez
Journal:  Mol Genet Genomic Med       Date:  2019-10-23       Impact factor: 2.183

9.  Alternative splicing after gene duplication drives CEACAM1-paralog diversification in the horse.

Authors:  Sophie Mißbach; Denis Aleksic; Lisa Blaschke; Timm Hassemer; Kyung Jin Lee; Martin Mansfeld; Jana Hänske; Johannes Handler; Robert Kammerer
Journal:  BMC Evol Biol       Date:  2018-03-15       Impact factor: 3.260

10.  Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease.

Authors:  Lei Pi; Di Che; Haifeng Long; Zhenzhen Fang; Jiawen Li; Shuyi Lin; Yunfeng Liu; Meiai Li; Lijuan Bao; Wenli Li; Yuan Zhang; Qiulian Deng; Techang Liu; Li Zhang; Xiaoqiong Gu
Journal:  Drug Des Devel Ther       Date:  2018-05-23       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.